NCT00938158 A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects. Status COMPLETED Phase PHASE1
NCT00938041 Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody Status COMPLETED Phase PHASE2
NCT00937950 Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects Status COMPLETED Phase PHASE3
NCT00937872 A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT00937846 Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study Status COMPLETED Phase PHASE1
NCT00937404 Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix) in Infants Status COMPLETED Phase PHASE1
NCT00937326 Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects Status COMPLETED Phase PHASE2
NCT00936195 Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial Status WITHDRAWN Phase PHASE3
NCT00935831 Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment Status COMPLETED Phase PHASE1
NCT00933530 A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT00933335 Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab Status COMPLETED Phase PHASE2
NCT00933062 Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT00931086 Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99 Status NO_LONGER_AVAILABLE Phase N/A
NCT00930527 Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors Status TERMINATED Phase PHASE2
NCT00929526 Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study Status COMPLETED Phase PHASE3
NCT00929370 A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam. Status TERMINATED Phase PHASE1
NCT00929331 Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years Status COMPLETED Phase PHASE3